Biostatistics TRIZ Cases

Graph-based embedding and clustering preserve shared metagenomic patterns, improving patient stratification and biomarker gene discovery.

Target-specific ML predicts protein binding affinity in silico, filtering weak candidates early to cut design time and experimental waste.

Alternating MSA and pair embedding updates let a neural network predict protein structures quickly without exhaustive search.

Vibrational spectral data and machine learning quantify tissue unmasking status, helping optimize retrieval without tissue degradation.

Probabilistic clustering of microbial gene expression preserves intermediate disease states and identifies discriminatory genes for patient stratification.

3D molecular graphs help predict PROTAC properties more accurately, improving drug discovery efficiency without relying on simpler low-precision models.

Pseudo-random bin assignment reduces sort-seq bias and improves mean fluorescence estimates for sequencing-based cell library characterization.

Rotational diffusion and reduced backbone frames enable realistic protein structure and sequence generation with lower computational burden.

Higher-order joint cumulants and network embedding reveal complex genotype-phenotype biomarkers while reducing false positives in disease analysis.

Energy-distribution learning predicts protein-ligand binding conformations and affinities with less training data and lower compute.

Machine learning designs mismatched, asymmetric oligonucleotides to detect polymorphic nucleic acid sequences with higher sensitivity and specificity.

Deep learning maps mixed tumour scRNA-seq profiles into latent clusters to separate malignant and microenvironment cells for better annotation.

A multi-scale neural network predicts protein dihedral angles from amino acid sequences, cutting folding verification time from days to seconds.

Joint neural prediction of MHC binding and cell-surface presentation improves neoantigen selection for personalized cancer vaccines.

Latent-space encoding with an autoregressive decoder generates functional protein variants without explicit fold prediction.

Multi-scale residual routes and self-attention capture whole-read genomic context, improving classification accuracy beyond fixed k-mer methods.

Ranks patient-specific neoantigen epitopes by combining HLA binding, T-cell response, and RNA data to improve immunotherapy targeting.

A two-stage LLM and literature validation workflow improves gene prioritization speed while reducing hallucination risk and weak biological context.

K-mer clustering and in silico screening speed de novo qPCR primer-probe design for evolving pathogens while improving assay specificity.

Phenotype similarity subscores and machine learning rank gene associations beyond perfect genotype matches, improving detection of milder disorders.

Noisy training sequences smooth the energy landscape, helping protein design models avoid overfitting and generate more diverse viable candidates.

A general expression transformer predicts cell-type-specific gene regulation, distal regulatory elements, and non-coding variant effects.

Spatial transcriptome analysis maps administered cells in tissue with higher resolution than PCR or tracers, revealing distribution and therapeutic mechanisms.

AI converts sequence, structural, and physicochemical protein features into graph data to speed screening of animal-protein alternatives.

Machine learning replaces subjective manual gating in flow cytometry to classify cell populations more accurately and support clinical decisions.

Generates and thermodynamically ranks multiple RNA tertiary structures to predict small-molecule binding despite scarce solved RNA data.

Guided diffusion sampling uses modular energy functions to generate novel protein backbones that satisfy target design conditions.

A structure-based energy model predicts T cell-antigen specificity for unseen TCRs by separating meaningful binders from non-specific pairs.

A multi-module detection model combines high-recall site screening with precision filtering to improve low-frequency mutation calling.

A set-theory-based differentiation value separates favorable from unfavorable shared DNA trios for reliable real-time ancestry reporting.

Empirical spectrum-centric results refine predicted DIA libraries, improving peptide identification, speed, and proteome coverage without extra measurements.

Uses amino acid sequences and 3D coordinate vectors to improve receptor-ligand compatibility prediction beyond atomic-level formulas.

Compound-protein interaction embeddings improve bioactivity prediction accuracy and flexibility while helping identify proteins driving results.

Weighted fusion of CNV, histopathology, and clinical ML outputs classifies breast cancer subtypes without costly RNA profiling.

Pre-end, post-end, 5′ and 3′ cfDNA motifs are combined in multidimensional ML models to improve pathology classification accuracy.

Machine learning filters false fragments and matches mass offsets to improve protein modification detection in complex native mass spectra.

A two-model pipeline combines peptide-MHC binding predictions with MHC-unrestricted calibration to improve immunogenic response prediction.

Density-based clustering and Gaussian models improve CNV calling accuracy and throughput without in-plate controls by compensating for plate effects.

Phenomic embeddings, gene clustering, and clinical feature filtering improve causal prediction accuracy despite noisy, high-dimensional data.

Multi-attribute drug and target association matrices improve feature extraction and raise drug-target interaction prediction accuracy.

Highly palindromic promoter subsequences are selected and concatenated to create shorter enhancers that preserve activity and tissue specificity.

Tensor regression restructures high-dimensional multi-omics data to detect complex disease associations with efficient estimation and prediction.

Machine-learned screening maps oligonucleotide sequences to biophysical effects, cutting OBM discovery time and improving tissue targeting.

Single-cell 'omics mapping into phenotypic space guides drug combinations away from resistance states to reduce recurrence and metastasis.

Population-wide linkage disequilibrium estimates predict gamete breeding value variation, helping breeders choose matings more likely to yield superior offspring.

Machine learning predicts peptide synthesis and solubility risk before production, helping reduce manufacturing failures and QC issues.

A replacement-matrix scan narrows peptide substitutions, cutting synthesis and testing while preserving specificity and sensitivity.

A heterogeneous graph links crop genotypes, environments, and phenotype data to improve genomic prediction accuracy across target conditions.

Joint denoising of amino acid sequences and 3D structures improves protein binding affinity and stability while reducing search burden.

SPLASH-derived k-mer anchor-target tokens compress genetic sequence context to speed transformer training and improve signal resolution.